Risks and benefits of activated protein C treatment for severe sepsis.

被引：171
|
作者：
Warren, HS [1 ]
Suffredini, AF
Eichacker, PQ
Munford, RS
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] NIH, Bethesda, MD 20892 USA
[3] Univ Texas, SW Med Ctr, Dallas, TX 75390 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2002年 / 347卷 / 13期
关键词：
D O I：
10.1056/NEJMsb020574
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1027 / 1030
页数：4
相关论文
共 50 条
  • [21] Human recombinant activated protein C for severe sepsis
    Marti-Carvajal, A.
    Salanti, G.
    Cardona, A. F.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [22] Human recombinant activated protein C for severe sepsis
    Marti-Carvajal, Arturo J.
    [J]. ANESTHESIA AND ANALGESIA, 2008, 106 (01): : 346 - 346
  • [23] Role of activated protein C in the pathophysiology of severe sepsis
    Dettenmeier, P
    Swindell, B
    Stroud, M
    Arkins, N
    Howard, A
    [J]. AMERICAN JOURNAL OF CRITICAL CARE, 2003, 12 (06) : 518 - 524
  • [24] Activated protein C in a pregnant patient with severe sepsis
    Mahabeer, N
    Zwaal, J
    [J]. HOSPITAL MEDICINE, 2005, 66 (02): : 124 - 124
  • [25] ACTIVATED PROTEIN C AND GENE POLYMORPHISM IN SEVERE SEPSIS
    de la Torre-Prados, M. -V.
    Garcia-de la Torre, A.
    Garcia-Alcantara, A.
    Salazar-Ramirez, C.
    Ortiz-Garcia, C.
    Enguix-Armada, A.
    [J]. INTENSIVE CARE MEDICINE, 2009, 35 : 168 - 168
  • [26] Activated protein c attenuates plasma and hepatic proinflammatory cytoiunes after trauma and sepsis.
    Huynh, Toan
    Keller, Steve
    Clemens, Mark G.
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (12) : A44 - A44
  • [27] Endothelial protein C activation in meningococcal sepsis.
    Kao, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (24): : 1776 - 1776
  • [28] RECOMBINANT HUMAN ACTIVATED PROTEIN C AND CONSUMPTION OF PROTEIN C IN SEVERE SEPSIS
    Garcia de la Torre, A.
    de la Torre-Prados, M. V.
    Nieto-Gonzalez, M.
    Ortiz-Garcia, C.
    Garcia-Alcantara, A.
    Enguix-Armada, A.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 36 - 37
  • [29] Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies
    Altaweel, Laith
    Sweeney, Daniel
    Cui, Xizhong
    Barochia, Amisha
    Natanson, Charles
    Eichacker, Peter Q.
    [J]. BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 391 - 406
  • [30] The efficacy and safety of recombinant human activated protein C for the treatment of patients with severe sepsis
    Bernard, GR
    LaRosa, SP
    Laterre, PF
    Ely, EW
    Dhainaut, JF
    Fisher, CJ
    Rodriquez, A
    Helterbrand, J
    Steingrub, J
    Garber, G
    Vincent, JL
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (12) : A48 - A48
12345